Atreca Inc Cl A (BCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCEL | AMGN | VRTX | REGN | GILD |
| Company | Atreca Inc Cl A | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0950 | 311.49 | 477.52 | 1,042.28 | 68.24 |
| High | 0.0950 | 312.54 | 477.52 | 1,047.25 | 68.33 |
| Low | 0.0900 | 309.75 | 469.65 | 1,031.71 | 67.23 |
| Last | 0.0900 | 311.36 | 470.21 | 1,031.96 | 67.22 |
| Change | -0.0012 | +0.59 | -3.57 | -12.70 | -1.18 |
| % Change | -1.32% | +0.19% | -0.75% | -1.22% | -1.73% |
| Volume | 138,600 | 102,430 | 140,006 | 26,600 | 383,527 |
| 20-Day Average Volume | 104,865 | 2,344,785 | 1,232,790 | 460,182 | 9,010,244 |
| Previous Close | 0.0912 | 310.77 | 473.78 | 1,044.66 | 68.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0907 | 307.93 | 475.73 | 1,036.88 | 66.69 |
| 20-Day Raw Stochastic | 57.69% | 52.40% | 40.14% | 49.66% | 51.84% |
| 20-Day Relative Strength | 46.67% | 56.40% | 59.54% | 57.51% | 51.83% |
| Weighted Alpha | -88.45 | +36.77 | +41.21 | +45.49 | -11.85 |
| Today's Opinion | 56% Sell | 100% Buy | 88% Buy | 88% Buy | 40% Sell |
| Previous Opinion | 40% Sell | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 72% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 06/07/24 | -0.44% since 06/26/24 | -0.31% since 06/26/24 | -3.18% since 06/26/24 | -2.46% since 06/26/24 |
| Low | 0.0864 on 06/10/24 | 307.64 on 07/02/24 | 467.41 on 07/02/24 | 1,030.23 on 07/02/24 | 67.58 on 07/02/24 |
| High | 0.0950 on 06/14/24 | 319.00 on 07/01/24 | 478.96 on 07/01/24 | 1,073.05 on 06/27/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | -5.26% since 05/14/24 | +1.31% since 06/03/24 | +0.50% since 06/03/24 | +4.62% since 06/03/24 | +6.59% since 06/03/24 |
| Low | 0.0750 on 06/07/24 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 986.64 on 06/04/24 | 62.69 on 06/18/24 |
| High | 0.1010 on 05/21/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -54.77% since 03/14/24 | +13.49% since 04/03/24 | +15.59% since 04/03/24 | +8.86% since 04/03/24 | -4.63% since 04/03/24 |
| Low | 0.0520 on 03/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 0.2000 on 03/15/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | -63.27% since 12/14/23 | +3.58% since 01/03/24 | +15.05% since 01/03/24 | +12.82% since 01/03/24 | -19.01% since 01/03/24 |
| Low | 0.0520 on 03/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 0.4448 on 01/12/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,566 | 166,707,904 | 122,260,352 | 115,106,896 | 85,216,352 |
| Shares Outstanding, K | 39,624 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -97,160,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -36,220,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.03 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/14/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 06/19/24 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.69 | 31.29 | 28.48 | 17.03 |